Studies report that mRNA-based cancer vaccines are being evaluated in clinical trials for melanoma, showing ability to generate tumor-specific immune responses and support immunotherapy approaches in recent oncology research
pmc.ncbi.nlm.nih.govu/ChhotaSaHydra — 17 hours ago